Influencing Factors of Urinary Iodine Concentration Before and After Radioiodine Therapy for Differentiated Thyroid Cancer: An Initial Exploration of the Relationship With Therapeutic Efficacy
Cancer Control · 2024
DOI: 10.1177/10732748241292786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Control, 2024. Verfasst von Qian Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Iodine Radioisotopes, Thyroglobulin, Iodine. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sichuan Provincial Science and Technology Department General Project, Chengdu City Technology Innovation and Research Development Project, Sichuan Provincial Medical Youth Innovation Research Project.
Abstract (Originalsprache)
Objective
To investigate the impact of urinary iodine concentration (UIC) and post-stimulatory thyroglobulin (ps-Tg) levels on the therapeutic efficacy of differentiated thyroid cancer (DTC) patients after initial radioiodine therapy, and to analyze the validity of these indicators as prognostic factors.
Methods
A total of 213 DTC patients received initial radioiodine therapy from June 2022 to September 2023. Demographic data and UIC were collected before and after therapy. Thyrotropin, thyroglobulin (Tg), and thyroglobulin antibody levels were assessed. Iodine uptake rate was measured, and therapeutic efficacy was evaluated 6 months post-therapy. Statistical tests were used for data comparison, and logistic regression analysis for response factors.
Results
Post-therapy UIC and pre-post UIC difference were significantly correlated with Tg levels but not with reaching excellent response (ER) indicated by suppression of Tg levels below 0.2 ug/L. Ps-Tg levels related to therapeutic efficacy, while UIC did not correlate with outcomes. ROC curve analysis found optimal ps-Tg cut-off points for the low-intermediate and high-risk groups classified by primary tumor size, invasion, metastasis, and pathological type.
Conclusion
Post-treatment UIC and pre-post UIC difference correlate with ps-Tg levels. Ps-Tg levels are an associated factor for DTC, but UIC changes, despite correlation with ps-Tg, are not significantly related to outcomes and cannot be used as a prognostic factor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, China.
ORCID-Profile: Qian Liu
Förderung
- Sichuan Provincial Science and Technology Department General Project
- Chengdu City Technology Innovation and Research Development Project
- Sichuan Provincial Medical Youth Innovation Research Project
- China Baoyuan Research Fund Project
Zitieren
APA
Liu, Q., Zhou, H., Xia, Y., Huang, Y., Liu, L., Jiang, X., & Shi, Y. (2024). Influencing Factors of Urinary Iodine Concentration Before and After Radioiodine Therapy for Differentiated Thyroid Cancer: An Initial Exploration of the Relationship With Therapeutic Efficacy. Cancer Control. https://doi.org/10.1177/10732748241292786
Vancouver
Liu Q, Zhou H, Xia Y, Huang Y, Liu L, Jiang X, et al. Influencing Factors of Urinary Iodine Concentration Before and After Radioiodine Therapy for Differentiated Thyroid Cancer: An Initial Exploration of the Relationship With Therapeutic Efficacy. Cancer Control. 2024. doi:10.1177/10732748241292786
BibTeX
@article{Liu2024,
author = {Liu, Qian and Zhou, Huan and Xia, Yuxiao and Huang, Ying and Liu, Lina and Jiang, Xue and Shi, Yuhong},
title = {Influencing Factors of Urinary Iodine Concentration Before and After Radioiodine Therapy for Differentiated Thyroid Cancer: An Initial Exploration of the Relationship With Therapeutic Efficacy},
journal = {Cancer Control},
year = {2024},
doi = {10.1177/10732748241292786}
}
EUVIMED